Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
This colorectal tumor-on-chip model is an original and reliable platform for high-throughput drug screening and genetic expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Design and characterization of the microfluidic chip. (A) Profilometer characterization: 3D map of the microfluidic chip. Representative image of quality control and characterization of the microfluidic chip features. The central chamber is 5 mm in diameter and 126 μm in depth, with a separate inlet and outlet for hydrogel injection. The two lateral channels, each 100 μm in width and 126 μm in depth, are not interconnected, opening up the possibility of perfusing two distinct solutions. (B) Schematic of chip design and zoom-in image of the concept of colorectal tumor-on-a-chip model: Round microfluidic central chamber in which HCT-116 cancer cells are embedded in Matrigel; HCoMECs are seeded in the side channels to form a 3D vessel-like assembly. (C) Establishment of a microvascular 3D microenvironment of colorectal tumor-on-a-chip: HCT-116 CRC cells embedded in Matrigel (in central chamber, stained in red) and HCoMECs (in lateral microchannels, stained in yellow) at day 1 (1D) and day 5 (5D) of culture. Endothelial cells start to invade the central chamber filled with Matrigel in response to VEGF presence. (D) Fluorescence microscopy image of microfluidic lateral channel mimicking prevascularization with HCoMECs after 5 days of culture [4′,6-diamidino-2-phenylindole (DAPI) blue, nuclei; phalloidin green, F-actin filaments]. Representative fluorescence microscopy close-up image of microchannel cross section showing endothelial cells aligning and creating an endothelialized lumen within the microchannel.](https://figures.cochat.ai/paper-figures/e6920bdb0956445d8d19309ea14d3e31/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-1.jpg)

![Fig. 3 Schematic representation of fluorescent nanoparticle gradient formation. (A) Transmission electron microscopy image of individual CMCht/PAMAM dendrimer nanoparticle, representative image of chip connected to tubing perfusing the nanoparticle solution, and zoom-in confocal microscopy image confirming FITC-labeled CMCht/PAMAM dendrimer nanoparticles’ dispersion in Matrigel. (B) Panel of fluorescence microscopy images of FITC-labeled nanoparticle gradient up to 12 hours. (C) Quantification of fluorescence: Intensity [in arbitrary units (a.u.)] versus distance (in micrometers) across the chip up to 12 hours [measurements according to the direction of the green arrow indicated in (B)]. (D) 3D projection of FITC-labeled nanoparticle gradient according to fluorescence intensity.](https://figures.cochat.ai/paper-figures/708a4d00001f4aab95398541a1dadede/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-3.jpg)
![Fig. 4 GEM drug effect on colorectal tumor model. (A) Release profile of GEM: Cumulative release (in hours) of GEM at pH 7.4 in phosphate-buffered saline (PBS), at 37°C and stirred at 60 rpm, determined by ultraviolet (UV) spectrophotometer set to 275 nm. The results are expressed as means ± SD (n = 6). (B) Schematic representation of experimental setup [perfusion of culture medium through one inlet and one outlet and of culture medium supplemented with GEM-loaded dendrimer nanoparticles (0.5 mg/ml) through the other inlet and outlet]; the areas defined for cell death quantification are delimited by dashed lines, and each ring is assigned D1 to D3 and M1 to M3. (C) Representative images of fluorescence microscopy images of live/dead assay performed on microfluidic chip at days 1 and 5. (D) Quantification of cell death, represented as percentage, based on the microscopy data. Data are presented as means ± SD (n = 3). The asterisk (*) denotes statistical differences (P < 0.05). Scale bars, 1000 μm. NP, nanoparticle; CTRL, control.](https://figures.cochat.ai/paper-figures/27813f8b3257452bb0dbcf8a091e4f62/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-4.jpg)
![Fig. 5 Gene expression analysis and immunocytochemistry on a chip. (A) Representation of hydrogel retrieval containing HCT-116 cells from the chip for gene expression analysis. (B) Gene expression of Ki-67, Casp-3, and MMP-1, in the absence (control) and presence of GEM, at days 1 and 5. The values for controls are represented by the dashed line. The asterisk (*) indicates significant differences when comparing the same condition at two different time points. The hash key (#) indicates significant differences when comparing to controls at the same time point. Data represent mean values of three independent experiments ± SD. RPS27A, ribosomal protein S27A. (C) Immunohistochemistry: In the center, a representative schematic of the entire chip that has reused an image from Fig. 4C (GEM NP gradient, top left) is depicted. The lateral images represent the zoom in at the cell level showing the immunocytochemistry Ki-67 staining after 5 days in culture [panels showing DAPI nuclei staining (blue), Ki-67 staining (green), F-actin staining (red), and merged image in colors].](https://figures.cochat.ai/paper-figures/67019409de02432a8df9bda6665dcdc4/colorectal-tumor-on-a-chip-system-a-3d-tool-for-precision-onco-nanomedicine-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The platform was inspired by radial drug penetration (diffusion of small molecules from the outer boundaries into the central core of the tumor) into solid tumors, and it evaluated in real-time the interactions between colorectal cancer cells and endothelial cells that in fi ltrated the VEGF-infused tumor core [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To mimic the human colorectal TME and reconstitute functions of the microvascular tissue, a 3D micro fl uidic chipbased in vitro model was fabricated [72].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [72]
In the citing paper
“The microvascularized colorectal-tumor-on-a-chip model was developed to investigate sprouting formation and drug screening applications.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
In the citing paper
“CRC cells, labeled in red, and HCoMECs, in yellow, respond to the incoming VEGF growth factor.”
From Tumor-on-a-chip: from bioinspired design to biomedical application (2021) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.213 · Cited by 1,434 · cited 1×
“Angiogenesis is a complex morphogenetic process where endothelial cells from preexisting vessels invade the matrix as multicellular sprouts to form new vessels (29).”
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions
Chen, X.-G., & Park, H.-J. (2003) · Carbohydrate Polymers · doi:10.1016/s0144-8617(03)00051-1 · Cited by 784
Biomolecular gradients in cell culture systems
Keenan, T. M., & Folch, A. (2008) · Lab Chip · doi:10.1039/b711887b · Cited by 596
Filopodia in cell adhesion, 3D migration and cancer cell invasion
Jacquemet, G., Hamidi, H., & Ivaska, J. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.007 · Cited by 533
Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro
Nguyen, D.-H. T., Stapleton, S. C., Yang, M. T., Cha, S. S., Choi, C. K., Galie, P. A., & Chen, C. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221526110 · Cited by 493
Weis, S., Cui, J., Barnes, L., & Cheresh, D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408130 · Cited by 477
Cited by
Patient-derived xenograft models in cancer therapy: technologies and applications
Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01419-2 · Cited by 494
Multifunctional biomolecule nanostructures for cancer therapy
Wang, J., Li, Y., & Nie, G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00315-x · Cited by 488
Obstacles and opportunities in a forward vision for cancer nanomedicine
de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 439
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
“To mimic the human colorectal TME and reconstitute functions of the microvascular tissue, a 3D microfluidic chipbased in vitro model was fabricated [72].”
BackgroundMethodSelf-citationTumor microenvironment: barrier or opportunity towards effective cancer therapy
Tiwari, A., Trivedi, R., & Lin, S.-Y. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00866-3 · Cited by 377
“Furthermore, the effects of different growth factors (GFs) or drugs in a biomimetic microenvironment and stromadriven ECM remodeling can also be studied using these microfluidic chip-based in vitro 3D models with a high degree of monitoring [240, 241].”
Background
Metadata
- Authors
- Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P.
- Affiliations
- 3B's Research Group (PT)
- Maastricht University (NL)
- Department of Instructive Biomaterials Engineering, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Netherlands.
- Corresponding author
- Oliveira, J. M.
- ORCID
- Venue
- Science Advances
- Published
- 2019-05-03
- Volume
- 5
- Issue
- 5
- Pages
- eaaw1317-eaaw1317
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6531003
- OpenAlex
- W2946416309
- Cited by
- 230
- References
- 49
- Citations by year
- 2026: 18 · 2025: 26 · 2024: 44 · 2023: 40 · 2022: 32 · 2021: 38 · 2020: 29 · 2019: 3
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- EMBO (Short-Term Fellowship 7232)
- FCT (NORTE-01-0145-FEDER-000023, IF/01285/2015)
- Norte Portugal Regional Operational Programme (NORTE-08-5369-FSE- 000044)
- IET A F Harvey Engineering (IET A F Harvey Engineering Research Prize 2018 (ENG ThE CANCER))
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- colorectal cancer, tumor-on-a-chip, 3D tumor models, precision nanomedicine, precision oncology, cancer nanomedicine
- MeSH terms
- Cell Survival, Humans, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Coculture Techniques, Ki-67 Antigen, Matrix Metalloproteinase 1, Imaging, Three-Dimensional, Biomimetics, Microfluidics, HCT116 Cells, Cell Line, Tumor, Dendrimers, Nanomedicine, Caspase 3, Nanoparticles, Lab-On-A-Chip Devices, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine. https://app.cochat.ai/papers/10.1126/sciadv.aaw1317
- The paper
- Carvalho, M. R., Barata, D., Teixeira, L. M., Giselbrecht, S., Reis, R. L., Oliveira, J. M., Truckenmüller, R., & Habibovic, P. (2019). Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine. Science Advances. https://doi.org/10.1126/sciadv.aaw1317
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.